PharmAust (PAA) News Today

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)

Stock Analysis

Source

Source	Headline
	PharmAust inks approval from Macquarie University for Open-Label MND extension study msn.com - April 10 at 7:50 AM
	We Think PharmAust (ASX:PAA) Can Afford To Drive Business Growth finance.yahoo.com - March 27 at 2:46 AM
	Closing Bell: ASX a little lower after hosting a Big 4 bank midweek spank msn.com - March 14 at 2:07 AM
	PharmAust files groundbreaking MND/ALS clinical data with the FDA msn.com - March 14 at 2:07 AM
	If you'd put $30,000 in this ASX biotech stock 4 months ago, you'd have $140,000 now fool.com.au - March 13 at 10:06 AM
	PharmAust advances monepantel for motor neurone disease towards FDA approval finance.yahoo.com - February 28 at 3:41 PM
	PharmAust Limited: PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS finanznachrichten.de - February 28 at 10:41 AM
	PharmAust’s MPL could offer MND/ALS sufferers up to 56.5 months additional life expectancy msn.com - February 28 at 10:41 AM
	PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS finance.yahoo.com - February 28 at 10:41 AM
	PharmAust forms scientific advisory board to guide next phase of monepantel for treatment of MND/ALS msn.com - February 21 at 8:07 PM
	FDA shows the way for accelerated approval of PharmAust’s monepantel in MND msn.com - February 16 at 2:40 AM
	PharmAust (ASX:PAA) delivers shareholders incredible 42% CAGR over 5 years, surging 11% in the last week alone finance.yahoo.com - February 14 at 8:16 PM
	PharmAust extension study begins as analysis shows MND/ALS drug ‘defied the odds’ msn.com - February 14 at 12:54 AM
	Plains All American Pipeline LP PAA morningstar.com - February 10 at 6:20 PM
	Plains All American Pipeline L.P. markets.businessinsider.com - February 1 at 12:15 AM
	Plains All American Stock (NASDAQ:PAA) Dividends: History, Yield and Dates benzinga.com - January 30 at 9:16 AM
	PharmAust gets ethics committee green light for open-label MND extension study msn.com - January 30 at 4:16 AM
	FDA offers PharmAust clear guidance for orphan drug designation approval msn.com - January 28 at 8:34 PM
	Plains All American Pipeline LP morningstar.com - January 23 at 8:08 PM
	PharmAust partners with US-based Berry Consultants for Phase 2/3 study msn.com - January 16 at 8:44 PM
	PharmAust just got a pre-IND meeting with the US FDA to kick off ‘24 msn.com - January 1 at 11:45 PM
	Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust msn.com - December 21 at 11:06 PM
	Santa (and ATO) delivers PharmAust $550k cash boost for Christmas msn.com - December 20 at 9:31 AM
	Prominent Perth fundie the main backer in PharmAust’s $3.5m cap raise msn.com - December 12 at 11:10 PM
	PharmAust Limited (ECQ.F) au.finance.yahoo.com - December 2 at 12:39 PM
	PharmAust completes Phase 1 motor neurone disease trial, applies for Orphan Drug Designation msn.com - November 30 at 11:28 PM
	Why this ASX biotech is primed to capitalise as big pharma flocks to the rare diseases market msn.com - November 21 at 11:16 PM
	PharmAust Ltd PAA morningstar.com - November 9 at 10:57 PM
	PharmAust eyes US orphan drug designation after successful phase 1 motor neurone disease trial msn.com - October 12 at 9:02 PM
	PharmAust races for access to the US market after confirming its canine cancer treatment is safe for pooches msn.com - October 8 at 11:59 PM
	PharmAust Full Year 2023 Earnings: AU$0.019 loss per share (vs AU$0.005 loss in FY 2022) finance.yahoo.com - September 2 at 10:00 PM
	New CEO to take the helm as PharmAust progresses clinical studies msn.com - August 28 at 2:37 AM
	Results from 11 out of 12 patients in PharmAust trial point to stabilised MND progression msn.com - August 22 at 5:17 AM
	Preliminary evidence for MPL activity enables PharmAust to commence planning a Phase 2 trial in motor neurone disease msn.com - August 8 at 11:34 PM
	PAA.AX - PharmAust Limited finance.yahoo.com - July 13 at 12:52 AM
	PharmAust secures more proof of MPL’s efficacy in stopping MND progression msn.com - July 11 at 3:46 AM
	PharmAust begins Cohort 3 dosing in Phase 1/2 motor neurone disease trial msn.com - June 9 at 1:53 AM
	PharmAust confirms safety of MPL, poised to up dosage in MND trial msn.com - May 22 at 1:22 AM
	PharmAust’s interim analysis to point the way forward for MND trial msn.com - May 16 at 12:04 AM
	PharmAust says its MPL drug has a long and stable shelf life msn.com - May 9 at 8:11 PM
	PharmAust’s MPL drug shows anti-cancer effects across multiple cancer types msn.com - May 9 at 12:09 AM
	PharmAust’s oversubscribed $2.5m placement highlights investor backing msn.com - May 3 at 1:41 AM
	PharmAust secures more MPL tablets to safeguard supply for motor neurone disease trial msn.com - April 17 at 10:25 AM
	PharmAust completes patient enrolment for MPL trial with sights on US$3.6 billion Motor Neurone Disease market msn.com - March 29 at 11:09 PM
	Here's Why We're Not At All Concerned With PharmAust's (ASX:PAA) Cash Burn Situation finance.yahoo.com - March 28 at 9:14 PM
	PharmAust’s MND trial progressing with ‘stable’ patient moving to higher dosage msn.com - March 27 at 11:10 PM
	PharmAust Limited (PAA.AX) uk.finance.yahoo.com - March 15 at 9:16 AM
	Louie the beagle is beating the odds thanks to PharmAust’s canine cancer trial msn.com - March 8 at 9:29 PM
	PharmAust eyes Phase-3 trial after positive results from canine cancer drug msn.com - March 6 at 10:08 PM
	PharmAust Limited afr.com - March 3 at 12:32 AM

Get PharmAust News Delivered to You Automatically

The #1 Opportunity of the decade? (Ad)

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

PAA Media Mentions By Week

PAA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PAA
News Sentiment
▼
0.64

0.52
▲
Average
Medical
News Sentiment

PAA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PAA Articles
This Week
▼
0

0
▲
PAA Articles
Average Week

Get PharmAust News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (ASX:PAA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

PharmAust (PAA) News Today

PAA Media Mentions By Week

PAA Media Sentiment

PAA News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info